# MPZ

## Overview
The MPZ gene encodes myelin protein zero, a transmembrane glycoprotein that is pivotal in the formation and maintenance of the myelin sheath in the peripheral nervous system. Myelin protein zero is primarily expressed by Schwann cells and functions as a homophilic adhesion molecule, facilitating the compaction and stabilization of myelin layers through its immunoglobulin-like extracellular domain. This structural protein is essential for efficient nerve signal transmission, as it ensures the compact assembly of myelin, which is crucial for nerve insulation and rapid signal conduction. The protein's transmembrane and cytoplasmic domains contribute to its oligomerization and proper cellular localization, respectively. Mutations in the MPZ gene are associated with various inherited neuropathies, including Charcot-Marie-Tooth disease type 1B and Dejerine-Sottas syndrome, underscoring its clinical significance in neural function and pathology (Warner1996Clinical; Shapiro1996Crystal; Raasakka2020How).

## Structure
Myelin protein zero (MPZ) is a transmembrane glycoprotein that plays a critical role in the formation and maintenance of myelin in the peripheral nervous system. The primary structure of MPZ includes a sequence of amino acids that form distinct domains: an N-terminal extracellular domain (ECD), a single transmembrane segment, and a C-terminal cytoplasmic domain (Plotkowski2007Transmembrane). The ECD is characterized by an immunoglobulin-like fold, which is crucial for its function in membrane adhesion and compaction (Wells1993Myelin). This domain is involved in homophilic interactions that facilitate the adhesion of myelin membranes, forming a compact structure essential for nerve function (Sakakura2023Structural).

The tertiary structure of MPZ involves a compact, immunoglobulin-like fold, which is similar to the variable domains of immunoglobulins, featuring ten β-strands arranged in two β-sheets (Shapiro1996Crystal). MPZ forms tetramers, which are stabilized through interactions in the membrane environment, representing its quaternary structure (Inouye1999Tetrameric). Post-translational modifications, such as glycosylation, are essential for MPZ's function, with the glycosylation site at Asn92 being fully occupied in some species (Xie2007Molecular). These structural features are critical for MPZ's role in myelin sheath formation and stability.

## Function
Myelin protein zero (MPZ) is a critical component of the myelin sheath in the peripheral nervous system, primarily expressed by Schwann cells. It plays a vital role in the compaction and stabilization of myelin, which is essential for efficient nerve signal transmission. MPZ functions as a homophilic adhesion molecule, facilitating the tight packing of myelin layers through its extracellular domain, which resembles an immunoglobulin-like structure. This domain is crucial for membrane adhesion, forming adhesive networks that maintain the native extracellular spacing of myelin lamellae (Shapiro1996Crystal; Raasakka2020How).

The cytoplasmic domain of MPZ is significant for its trafficking and insertion into the plasma membrane, with phosphorylation at specific serine and tyrosine residues being essential for its adhesive properties and proper cellular localization (Konde2006Myelin). MPZ's transmembrane domain also plays a role in oligomerization, forming dimers and tetramers that contribute to the structural integrity of the myelin sheath (Plotkowski2007Transmembrane).

In healthy cells, MPZ ensures the compact assembly of myelin, which is crucial for nerve insulation and rapid signal conduction. Disruptions in MPZ function can lead to peripheral neuropathies, highlighting its importance in maintaining neural function (Raasakka2020How).

## Clinical Significance
Mutations in the MPZ gene, which encodes myelin protein zero, are linked to several inherited neuropathies, most notably Charcot-Marie-Tooth disease type 1B (CMT1B) and Dejerine-Sottas syndrome (DSS). These conditions are characterized by muscle weakness and sensory loss due to defects in myelination (Roa1996Myelin; Warner1996Clinical). 

CMT1B can be categorized into early-onset and late-onset forms based on the age of onset and clinical severity. Early-onset mutations, such as H52R and S22_W28 deletion, result in severe demyelinating neuropathy with slow nerve conduction velocities (NCVs). These mutations disrupt MPZ function through mechanisms like gain of function or dominant-negative effects (Grandis2008Different). Late-onset mutations, such as T95M and H10P, are associated with milder neuropathy and normal NCVs, indicating a partial loss of function (Grandis2008Different).

The phenotypic variability of MPZ mutations is significant, with some mutations causing severe neuropathy and others leading to mild, slowly progressive conditions. Additional symptoms such as neuropathic pain, pupillary abnormalities, and hearing loss have been observed in some cases (Callegari2019Mutation). Understanding the specific molecular mechanisms of these mutations is crucial for developing targeted treatment strategies.

## Interactions
Myelin protein zero (MPZ) is a critical component of the myelin sheath in the peripheral nervous system, where it plays a significant role in membrane adhesion and myelin compaction. MPZ primarily engages in homophilic interactions, which are essential for the structural integrity of the myelin sheath. The extracellular domain (ECD) of MPZ facilitates these interactions, forming tetramers that can link with tetramers on opposing membranes to create adhesive networks. This structural arrangement is crucial for maintaining the native extracellular spacing of adjacent myelin lamellae (Shapiro1996Crystal).

The transmembrane (TM) domain of MPZ also plays a role in protein interactions, forming homodimers through a glycine zipper motif. This motif is significant for TM helix packing, and mutations within this region can disrupt dimerization, potentially affecting MPZ's function (Plotkowski2007Transmembrane). Additionally, MPZ's interactions are not limited to homophilic binding; the protein can also engage in cis and head-to-head interactions, forming an 8-mer structure responsible for membrane stacking. These interactions are crucial for the stability and function of MPZ in myelin compaction (Sakakura2023Structural).


## References


[1. (Sakakura2023Structural) Masayoshi Sakakura, Mikio Tanabe, Masaki Mori, Hideo Takahashi, and Kazuhiro Mio. Structural bases for the charcot-marie-tooth disease induced by single amino acid substitutions of myelin protein zero. Structure, 31(11):1452-1462.e4, November 2023. URL: http://dx.doi.org/10.1016/j.str.2023.08.016, doi:10.1016/j.str.2023.08.016. This article has 2 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.str.2023.08.016)

[2. (Grandis2008Different) M. Grandis, T. Vigo, M. Passalacqua, M. Jain, S. Scazzola, V. La Padula, M. Brucal, F. Benvenuto, L. Nobbio, A. Cadoni, G. L. Mancardi, J. Kamholz, M. E. Shy, and A. Schenone. Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations. Human Molecular Genetics, 17(13):1877–1889, March 2008. URL: http://dx.doi.org/10.1093/hmg/ddn083, doi:10.1093/hmg/ddn083. This article has 67 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddn083)

[3. (Shapiro1996Crystal) Lawrence Shapiro, Joseph P. Doyle, Preston Hensley, David R. Colman, and Wayne A. Hendrickson. Crystal structure of the extracellular domain from p0, the major structural protein of peripheral nerve myelin. Neuron, 17(3):435–449, September 1996. URL: http://dx.doi.org/10.1016/s0896-6273(00)80176-2, doi:10.1016/s0896-6273(00)80176-2. This article has 333 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/s0896-6273(00)80176-2)

[4. (Warner1996Clinical) Laura E Warner, Max J Hilz, Stanley H Appel, James M Killian, Edwin H Kolodny, George Karpati, Stirling Carpenter, Gordon V Watters, Calvin Wheeler, David Witt, Adria Bodell, Eva Nelis, Christine Van Broeckhoven, and James R Lupski. Clinical phenotypes of different mpz (p0) mutations may include charcot–marie–tooth type 1b, dejerine–sottas, and congenital hypomyelination. Neuron, 17(3):451–460, September 1996. URL: http://dx.doi.org/10.1016/s0896-6273(00)80177-4, doi:10.1016/s0896-6273(00)80177-4. This article has 283 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/s0896-6273(00)80177-4)

[5. (Roa1996Myelin) Benjamin B. Roa, Laura E. Warner, Carlos A. Garcia, Donna Russo, Robert Lovelace, Phillip F. Chance, and James R. Lupski. Myelin protein zero (mpz) gene mutations in nonduplication type 1 charcot-marie-tooth disease. Human Mutation, 7(1):36–45, 1996. URL: http://dx.doi.org/10.1002/(sici)1098-1004(1996)7:1<36::aid-humu5>3.0.co;2-n, doi:10.1002/(sici)1098-1004(1996)7:1<36::aid-humu5>3.0.co;2-n. This article has 49 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/(sici)1098-1004(1996)7:1)

[6. (Wells1993Myelin) Christopher A. Wells, Raul A. Saavedra, Hideyo Inouye, and Daniel A. Kirschner. Myelin p0‐glycoprotein: predicted structure and interactions of extracellular domain. Journal of Neurochemistry, 61(6):1987–1995, December 1993. URL: http://dx.doi.org/10.1111/j.1471-4159.1993.tb07434.x, doi:10.1111/j.1471-4159.1993.tb07434.x. This article has 32 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1111/j.1471-4159.1993.tb07434.x)

[7. (Konde2006Myelin) Viren Konde and Joseph Eichberg. Myelin protein zero: mutations in the cytoplasmic domain interfere with its cellular trafficking. Journal of Neuroscience Research, 83(6):957–964, February 2006. URL: http://dx.doi.org/10.1002/jnr.20793, doi:10.1002/jnr.20793. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jnr.20793)

[8. (Plotkowski2007Transmembrane) Megan L. Plotkowski, Sanguk Kim, Martin L. Phillips, Anthony W. Partridge, Charles M. Deber, and James U. Bowie. Transmembrane domain of myelin protein zero can form dimers: possible implications for myelin construction. Biochemistry, 46(43):12164–12173, October 2007. URL: http://dx.doi.org/10.1021/bi701066h, doi:10.1021/bi701066h. This article has 37 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi701066h)

[9. (Xie2007Molecular) Bo Xie, Xiaoyang Luo, Cheng Zhao, Christina Marie Priest, Shiu-Yung Chan, Peter B. O’Connor, Daniel A. Kirschner, and Catherine E. Costello. Molecular characterization of myelin protein zero in xenopus laevis peripheral nerve: equilibrium between non-covalently associated dimer and monomer. International Journal of Mass Spectrometry, 268(2–3):304–315, December 2007. URL: http://dx.doi.org/10.1016/j.ijms.2007.08.007, doi:10.1016/j.ijms.2007.08.007. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ijms.2007.08.007)

[10. (Raasakka2020How) Arne Raasakka and Petri Kursula. How does protein zero assemble compact myelin? Cells, 9(8):1832, August 2020. URL: http://dx.doi.org/10.3390/cells9081832, doi:10.3390/cells9081832. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells9081832)

[11. (Callegari2019Mutation) Ilaria Callegari, C. Gemelli, A. Geroldi, F. Veneri, P. Mandich, M. D’Antonio, D. Pareyson, M. E. Shy, A. Schenone, V. Prada, and M. Grandis. Mutation update for myelin protein zero-related neuropathies and the increasing role of variants causing a late-onset phenotype. Journal of Neurology, 266(11):2629–2645, July 2019. URL: http://dx.doi.org/10.1007/s00415-019-09453-3, doi:10.1007/s00415-019-09453-3. This article has 27 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00415-019-09453-3)

[12. (Inouye1999Tetrameric) Hideyo Inouye, Hiro Tsuruta, Jan Sedzik, Keiichi Uyemura, and Daniel A. Kirschner. Tetrameric assembly of full-sequence protein zero myelin glycoprotein by synchrotron x-ray scattering. Biophysical Journal, 76(1):423–437, January 1999. URL: http://dx.doi.org/10.1016/s0006-3495(99)77209-7, doi:10.1016/s0006-3495(99)77209-7. This article has 37 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0006-3495(99)77209-7)